The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study
Open accessAbstract
Background Neurofibrillary pathology has a stereotypical progression in Alzheimer's disease (AD) that is encapsulated in the Braak staging scheme; however, some AD cases are atypical and do not fit into this scheme. We aimed to compare clinical and neuropathological features between typical and atypical AD cases.Methods AD cases with a Braak neurofibrillary tangle stage of more than IV were identified from a brain bank database. By use of thioflavin-S fluorescence microscopy, we assessed the density and the distribution of neurofibrillary tangles in three cortical regions and two hippocampal sectors. These data were used to construct an algorithm to classify AD cases into typical, hippocampal sparing, or limbic predominant. Classified cases were then compared for clinical, demographic, pathological, and genetic characteristics. An independent cohort of AD cases was assessed to validate findings from the initial cohort.Findings 889 cases of AD, 398 men and 491 women with age at death of 37-103 years, were classified with the algorithm as hippocampal sparing (97 cases [11%]), typical (665 [75%]), or limbic predominant (127 [14%]). By comparison with typical AD, neurofibrillary tangle counts per 0.125 mm(2) in hippocampal sparing cases were higher in cortical areas (median 13, IQR 11-16) and lower in the hippocampus (7.5, 5.2-9.5), whereas counts in limbic-predominant cases were lower in cortical areas (4.3, 3.0-5.7) and higher in the hippocampus (27, 22-35). Hippocampal sparing cases had less hippocampal atrophy than did typical and limbic-predominant cases. Patients with hippocampal sparing AD were younger at death (mean 72 years [SD 10]) and a higher proportion of them were men (61 [63%]), whereas those with limbic-predominant AD were older (mean 86 years [SD 6]) and a higher proportion of them were women (87 [69%]). Microtubule-associated protein tau (MAPT) H1H1 genotype was more common in limbic-predominant AD (54 [70%]) than in hippocampal sparing AD (24 [46%]; p=0.011), but did not differ significantly between limbic-predominant and typical AD (204 [59%]; p=0.11). Apolipoprotein E (APOE) ɛ4 allele status differed between AD subtypes only when data were stratified by age at onset. Clinical presentation, age at onset, disease duration, and rate of cognitive decline differed between the AD subtypes. These findings were confirmed in a validation cohort of 113 patients with AD.Interpretation These data support the hypothesis that AD has distinct clinicopathological subtypes. Hippocampal sparing and limbic-predominant AD subtypes might account for about 25% of cases, and hence should be considered when designing clinical, genetic, biomarker, and treatment studies in patients with AD.Funding US National Institutes of Health via Mayo Alzheimer's Disease Research Center, Mayo Clinic Study on Aging, Florida Alzheimer's Disease Research Center, and Einstein Aging Study; and State of Florida Alzheimer's Disease Initiative.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“clinical features lack specificity for a pathologic process, but rather indicate brain regions or systems affected by the disease process [3, 4].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [3]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Three major subtypes of AD can be classified by the relative density of hippocampal neurofibrillary tangles with respect to neocortical tangles [3].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Genetic analyses of APOE suggest APOE4 is more closely linked to typical or limbic predominant than hippocampal sparing AD [3].”
From The neuropathological diagnosis of Alzheimer's disease (2019) · cites this paper as [3]
The cited source says what the claim attributes to it.
In the citing paper
“Nonamnestic clinical presentations, that is, language, visuospatial, and executive disorders, may also be due to AD [63–66].”
From NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease (2018) · cites this paper as [65]
In the citing paper
“Another challenge of CPC studies is that the molecular, anatomic, and clinical changes of AD may not progress in a uniform fashion (7, 12-15).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [12]
In the citing paper
“and that not all AD cases fall within the same spatial continuum with regard to brain NFT distributions (12, 15, 151).”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [12]
In the citing paper
“Nevertheless, Braak staging also masks the fact that marked variability in pathologic lesion density across cases exists within a given Braak stage (7, 12)”
From Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature (2012) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Self-citationNeurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Amador‐Ortiz, C., Lin, W., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff‐Radford, N. R., Hutton, M. L., & Dickson, D. W. (2007) · Annals of Neurology · doi:10.1002/ana.21154 · Cited by 916
Self-citationAssociation of an Extended Haplotype in the Tau Gene with Progressive Supranuclear Palsy
Baker, M., Litvan, I., Houlden, H., Adamson, J., Dickson, D., Perez-Tur, J., Hardy, J., Lynch, T., Bigio, E., & Hutton, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.711 · Cited by 781
Self-citationBarker, W., Luis, C. A., Kashuba, A., Luis, M., Harwood, D. G., Loewenstein, D., Waters, C., Jimison, P., Shepherd, E., Sevush, S., et al. (2002) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-200210000-00001 · Cited by 714
Self-citation
Cited by
Sorted by citations
Items 301–400 of 971
The influence of Apolipoprotein E genotype on regional pathology in Alzheimer’s disease
Sabbagh, M. N., Malek‐Ahmadi, M. H., Dugger, B. N., Lee, K., Sue, L. I., Serrano, G. E., Walker, D. G., Davis, K. J., Jacobson, S. A., & Beach, T. G. (2013) · BMC Neurology · doi:10.1186/1471-2377-13-44 · Cited by 42
Different patterns of hippocampal tau pathology in Alzheimer’s disease and PART
Jellinger, K. A. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1894-z · Cited by 43
Nadal, L., Pierrick Coupé, A., Helmer, C., Manjón, J. V., Amieva, H., Tison, F., Dartigues, J., Catheline, G., & Planche, V. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.01.011 · Cited by 41
Novel Alzheimer’s disease subtypes identified using a data and knowledge driven strategy
Mitelpunkt, A., Galili, T., Kozlovski, T., Bregman, N., Shachar, N., Marcus-Kalish, M., & Benjamini, Y. (2020) · Scientific Reports · doi:10.1038/s41598-020-57785-2 · Cited by 40
Loss of forebrain BIN1 attenuates hippocampal pathology and neuroinflammation in a tauopathy model
Ponnusamy, M., Wang, S., Yuksel, M., Hansen, M. T., Blazier, D. M., McMillan, J. D., Zhang, X., Dammer, E. B., Collier, L. A., & Thinakaran, G. (2022) · Brain · doi:10.1093/brain/awac318 · Cited by 44
Magnin, É., Chopard, G., Ferreira, S., Sylvestre, G., Dariel, E., Ryff, I., Mertz, C., Lamidieu, C., Hidalgo, J., Tio, G., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-122335 · Cited by 43
Decreased prevalence of dementia associated with statins: a national population‐based study
Chuang, C., Lin, C., Lin, M., Sung, F., & Kao, C. ‐. (2014) · European Journal of Neurology · doi:10.1111/ene.12402 · Cited by 40
LATE-NC aggravates GVD-mediated necroptosis in Alzheimer’s disease
Koper, M. J., Tomé, S. O., Gawor, K., Belet, A., Schoor, E. V., Schaeverbeke, J. M., Vandenberghe, R. R., Vandenbulcke, M., Ghebremedhin, E., Otto, M., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01432-6 · Cited by 42
Opattová, A., Filipčík, P., Cente, M., & Novák, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121072 · Cited by 41
Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies
Spina, S., Brown, J. A., Deng, J., Gardner, R. C., Nana, A. L., Hwang, J.-H. L., Gaus, S. E., Huang, E. J., Kramer, J. H., Rosen, H. J., et al. (2019) · Brain · doi:10.1093/brain/awz122 · Cited by 40
Rujeedawa, T., Félez, E. C., Clare, I. C. H., Fortea, J., Strydom, A., Rebillat, A., Coppus, A. M. W., Levin, J., & Zaman, S. H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10194582 · Cited by 43
Falgàs, N., Allen, I. E., Spina, S., Grant, H. E., Piña‐Escudero, S. D., Merrilees, J. J., Gearhart, R., Rosen, H. J., Kramer, J. H., Seeley, W. W., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.15203 · Cited by 42
Dementia is associated with medial temporal atrophy even after accounting for neuropathologies
Woodworth, D. C., Sheikh‐Bahaei, N., Scambray, K. A., Phelan, M. J., Perez-Rosendahl, M. A., Corrada, M. M., Kawas, C. H., Sajjadi, S. A., & Initiative, A. D. N. (2022) · Brain Communications · doi:10.1093/braincomms/fcac052 · Cited by 39
Thalamic nuclei changes in early and late onset Alzheimer's disease
Forno, G., Saranathan, M., Contador, J., Guillen, N., Falgàs, N., Tort-Merino, A., Balasa, M., Sanchez-Valle, R., Hornberger, M., & Lladó, A. (2023) · Current Research in Neurobiology · doi:10.1016/j.crneur.2023.100084 · Cited by 39
Targeted drug delivery in neurodegenerative diseases: the role of nanotechnology
Dhariwal, R., Jain, M., Mir, Y. R., Singh, A., Jain, B., Kumar, P., Tariq, M., Verma, D., Deshmukh, K., Yadav, V. K., et al. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1522223 · Cited by 47
Pai, M., & Lee, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155480 · Cited by 39
Kawakatsu, S., Kobayashi, R., & Hayashi, H. (2017) · Neuropathology · doi:10.1111/neup.12364 · Cited by 39
Zhang, B., Lin, L., & Wu, S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201274 · Cited by 40
Giorgio, J., Jagust, W. J., Baker, S. L., Landau, S. M., Peter Tiňo, B., Kourtzi, Z., & Initiative, A. D. N. (2022) · Nature Communications · doi:10.1038/s41467-022-28795-7 · Cited by 40
Atypical Motor and Behavioral Presentations of Alzheimer Disease
Duker, A. P., Espay, A. J., Wszołek, Z. K., Rademakers, R., Dickson, D. W., & Kelley, B. J. (2012) · The Neurologist · doi:10.1097/nrl.0b013e3182675376 · Cited by 38
Self-citationTau and the fractionated default mode network in atypical Alzheimer’s disease
Putcha, D., Eckbo, R., Katsumi, Y., Dickerson, B. C., Touroutoglou, A., & Collins, J. A. (2022) · Brain Communications · doi:10.1093/braincomms/fcac055 · Cited by 39
Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome
Aiba, I., Hayashi, Y., Shimohata, T., Yoshida, M., Saito, Y., Wakabayashi, K., Komori, T., Hasegawa, M., Ikeuchi, T., Tokumaru, A. M., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad296 · Cited by 41
Clinical criteria for a limbic-predominant amnestic neurodegenerative syndrome
Corriveau‐Lecavalier, N., Botha, H., Graff‐Radford, J., Switzer, A. R., Przybelski, S. A., Wiste, H. J., Murray, M. E., Reichard, R. R., Dickson, D. W., Nguyen, A. T., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae183 · Cited by 47
Self-citationAlzheimer’s Disease: Genetic Polymorphisms and Rate of Decline
Schmidt, C., Wolff, M., von Ahsen, N., & Zerr, I. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000336790 · Cited by 40
Insulin Resistance as a Common Link Between Current Alzheimer’s Disease Hypotheses
Alves, S. S., da Silva-Júnior, R. M. P., Servilha‐Menezes, G., Homolak, J., Šalković‐Petrišić, M., & Garcia‐Cairasco, N. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210234 · Cited by 39
Liu, H., Kim, C., Haldiman, T., Sigurdson, C. J., Nyström, S., Nilsson, K. P. R., Cohen, M. L., Wısnıewskı, T., Hammarström, P., & Safar, J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101267 · Cited by 37
Vanhoutte, M., Semah, F., Sillaire, A. R., Jaillard, A., Petyt, G., Kuchcinski, G., Maureille, A., Delbeuck, X., Fahmi, R., Pasquier, F., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.08.009 · Cited by 37
Goyal, D., Tjandra, D., Migrino, R. Q., Giordani, B., Syed, Z., Wiens, J., & Initiative, A. D. N. (2018) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2018.06.007 · Cited by 42
Tau Subtypes of Alzheimer’s Disease Determined in vivo Using Flortaucipir PET Imaging
Charil, A., Shcherbinin, S., Southekal, S. S., Devous, M. D., Mintun, M. A., Murray, M. E., Miller, B. B., & Schwarz, A. J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190264 · Cited by 37
Self-citationATN status in amnestic and non-amnestic Alzheimer’s disease and frontotemporal lobar degeneration
Cousins, K. A. Q., Irwin, D. J., Wolk, D. A., Lee, E. B., Shaw, L. M. J., Trojanowski, J. Q., Re, F. D., Gibbons, G. S., Grossman, M., & Phillips, J. S. (2020) · Brain · doi:10.1093/brain/awaa165 · Cited by 39
Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype
Buciuc, M., Whitwell, J. L., Kasanuki, K., Graff‐Radford, J., Machulda, M. M., Duffy, J. R., Strand, E. A., Lowe, V. J., Graff‐Radford, N. R., Rush, B. K., et al. (2020) · Annals of Neurology · doi:10.1002/ana.25979 · Cited by 37
Self-citationMohanty, R., Mårtensson, G., Poulakis, K., Muehlboeck, J., Rodriguez‐Vieitez, E., Chiotis, K., Grothe, M. J., Nordberg, A. K., Ferreira, D., Westman, E., et al. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa192 · Cited by 39
What Is T+? A Gordian Knot of Tracers, Thresholds, and Topographies
Villemagne, V. L., Lopresti, B. J., Doré, V., Tudorascu, D., Ikonomović, M. D., Burnham, S. C., Minhas, D. S., Pascoal, T. A., Mason, N. S., Snitz, B. E., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.245423 · Cited by 37
Kloske, C. M., Dugan, A. J., Weekman, E. M., Winder, Z., Patel, E., Nelson, P. T., Fardo, D. W., & Wilcock, D. M. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab085 · Cited by 37
Frigerio, I., Boon, B. D. C., Lin, C., Graaf, Y. G.-D., Bol, J. G. J. M., Preziosa, P., Twisk, J. W. R., Barkhof, F., Hoozemans, J. J. M., Bouwman, F. H., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab281 · Cited by 38
Subtypes of Alzheimer’s disease: questions, controversy, and meaning
Vogel, J. W., & Hansson, O. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2022.02.001 · Cited by 41
Xu, X., Lin, L., Sun, S., & Wu, S. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0122 · Cited by 40
Alzheimer's disease phenotypes show different sleep architecture
Falgàs, N., Walsh, C. M., Yack, L. M., Simon, A. J., Allen, I. E., Kramer, J. H., Rosen, H. J., Joie, R. L., Rabinovici, G. D., Miller, B. L., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.12963 · Cited by 36
Peripheral and Central Glutamate Dyshomeostasis in Neurodegenerative Disorders
Onaolapo, A. Y., & Onaolapo, O. J. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666201015161919 · Cited by 37
Peer support for people living with rare or young onset dementia: An integrative review
Sullivan, M. P., Williams, V., Grillo, A., McKee‐Jackson, R., Camic, P. M., Windle, G., Stott, J. C. H., Brotherhood, E., & Crutch, S. J. (2022) · Dementia · doi:10.1177/14713012221126368 · Cited by 35
Regional proton magnetic resonance spectroscopy patterns in dementia with Lewy bodies
Graff‐Radford, J., Boeve, B. F., Murray, M. E., Ferman, T. J., Tosakulwong, N., Lesnick, T. G., Maroney‐Smith, M., Senjem, M. L., Gunter, J. L., Smith, G. E., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.001 · Cited by 36
Self-citationNguyen, T. V., Hayes, M. I., Zbesko, J. C., Frye, J. B., Congrove, N. R., Belichenko, N. P., McKay, B. S., Longo, F. M., & Doyle, K. P. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0603-4 · Cited by 34
Language and spatial dysfunction in Alzheimer disease with white matter thorn-shaped astrocytes
Resende, E. D. P. F., Nolan, A., Petersen, C., Ehrenberg, A. J., Spina, S., Allen, I. E., Rosen, H. J., Kramer, J. H., Miller, B. L., Seeley, W. W., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000008937 · Cited by 37
Simrén, J., Brum, W. S., Ashton, N. J., Benedet, A. L., Karikari, T. K., Kvartsberg, H., Sjons, E., Lussier, F. Z., Chamoun, M., Stevenson, J., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01142-0 · Cited by 34
Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72
Murray, M. E., Bieniek, K. F., Greenberg, M. B., DeJesus‐Hernandez, M., Rutherford, N. J., van Blitterswijk, M., Niemantsverdriet, E., Ash, P. E. A., Gendron, T. F., Kouri, N., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1161-2 · Cited by 34
Self-citationA biomarker study in long-lasting amnestic mild cognitive impairment
Cerami, C., Dodich, A., Iannaccone, S., Magnani, G., Santangelo, R., Presotto, L., Marcone, A., Gianolli, L., Cappa, S. F., & Perani, D. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0369-8 · Cited by 37
Primary Age-Related Tauopathy: An Elderly Brain Pathology Frequently Encountered during Autopsy
Kim, D., Kim, H.-S., Choi, S., Kim, B. C., Lee, M. C., Lee, K., & Lee, J.-H. (2019) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2019.03.14 · Cited by 34
APOE Effect on Amyloid-β PET Spatial Distribution, Deposition Rate, and Cut-Points
Toledo, J. B., Habes, M., Sotiras, A., Bjerke, M., Yong Fan, A., Weiner, M. W., Shaw, L. M. J., Davatzikos, C. A., Trojanowski, J. Q., & Initiative, A. D. N. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181282 · Cited by 36
Quantitative neuropathological assessment to investigate cerebral multi-morbidity
Attems, J., Neltner, J. H., & Nelson, P. T. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0085-y · Cited by 32
APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer’s Disease
Waring, J. F., Tang, Q., Robieson, W., King, D. P., Das, U., Dubow, J. S., Dutta, S., Marek, G. J., & Gault, L. M. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142589 · Cited by 35
Vemuri, P., Fields, J. A., Peter, J., & Klöppel, S. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000346 · Cited by 36
Multiple Subtypes of Alzheimer’s Disease Base on Brain Atrophy Pattern
Zhang, B., Lin, L., Wu, S., & Al-Masqari, Z. (2021) · Brain Sciences · doi:10.3390/brainsci11020278 · Cited by 33
Groot, C., Grothe, M. J., Mukherjee, S., Jelistratova, I., Jansen, I. E., van Loenhoud, A. C., Risacher, S. L., Saykin, A. J., Donald, C. L. M., Mez, J., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102660 · Cited by 31
Asymmetry of Hippocampal Tau Pathology in Primary Age-Related Tauopathy and Alzheimer Disease
Walker, J. M., Fudym, Y., Farrell, K. W., Iida, M. A., Bieniek, K. F., Seshadri, S. S., White, C. L., Crary, J. F., & Richardson, T. E. (2021) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlab032 · Cited by 33
Varón, D., Barker, W., Loewenstein, D., Greig, M. T., Peñaranda, A. P. B., Santos, I., Shen, Q., Harper, M., Vallejo-Luces, T., Duara, R., et al. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4126 · Cited by 34
Self-citationBiological markers of Alzheimer?s disease
de Souza, L. C., Sarazin, M., Teixeira, A. L., Caramelli, P., dos Santos, A. M., & Dubois, B. (2014) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20130233 · Cited by 33
Visuoconstructional Impairment in Subtypes of Mild Cognitive Impairment
Ahmed, S., Brennan, L., Eppig, J. S., Price, C. C., Lamar, M., Delano‐Wood, L., Bangen, K. J., Edmonds, E. C., Clark, L., Nation, D. A., et al. (2015) · Applied Neuropsychology Adult · doi:10.1080/23279095.2014.1003067 · Cited by 36
Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction
Kang, S. W., Jeon, S., Yoo, H. S., Chung, S. J., Lee, P. H., Sohn, Y. H., Yun, M., Evans, A. C., & Ye, B. S. (2019) · Neurology · doi:10.1212/wnl.0000000000007373 · Cited by 31
Katsumata, Y., Fardo, D. W., Bachstetter, A. D., Artiushin, S., Wang, W., Wei, A. L., Brzezinski, L. J., Nelson, B. G., Huang, Q., Abner, E. L., et al. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz116 · Cited by 32
Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease
Mohanty, R., Ferreira, D., Frerich, S., Muehlboeck, J., Grothe, M. J., Westman, E., & Initiative, A. D. N. (2022) · Neurology · doi:10.1212/wnl.0000000000200573 · Cited by 32
Zafar, S., Shafiq, M., Younas, N., Schmitz, M., Ferrer, I., & Zerr, I. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170237 · Cited by 31
Hippocampal Sclerosis in the Oldest Old: A Finnish Population-Based Study
Kero, M., Raunio, A., Polvikoski, T. M., Tienari, P. J., Paetau, A. E., & Myllykangas, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-171068 · Cited by 32
Souza, L. C. D., Bertoux, M., Funkiewiez, A., Samri, D., Azuar, C., Habert, M.-O., Kas, A., Lamari, F., Sarazin, M., & Dubois, B. (2013) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642013dn70100011 · Cited by 31
A generalizable data-driven model of atrophy heterogeneity and progression in memory clinic settings
Baumeister, H., Vogel, J. W., Insel, P. S., Kleineidam, L., Wolfsgruber, S., Stark, M., Gellersen, H. M., Yakupov, R., Schmid, M. C., Lüsebrink, F., et al. (2024) · Brain · doi:10.1093/brain/awae118 · Cited by 33
Falgàs, N., Peña‐González, M., Val‐Guardiola, A., Pérez‐Millan, A., Guillén, N., Sarto, J., Esteller, D., Bosch, B., Fernández‐Villullas, G., Tort‐Merino, A., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14131 · Cited by 35
Koper, M. J., Moonen, S., Ronisz, A., Ospitalieri, S., Callaerts‐Vegh, Z., T’Syen, D., Rabe, S., Staufenbiel, M., Strooper, B. D., Balusu, S., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adf5128 · Cited by 32
Samat, H. N. A., Razali, N. N., Mahadzir, H., Muhammad, T. S. T., Ling, K., Mansor, N. I., & Abidin, S. Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188905 · Cited by 34
Higher Working Memory Predicts Slower Functional Decline in Autopsy-Confirmed Alzheimer's Disease
Pillai, J. A., Bonner‐Jackson, A., Walker, E., Mourany, L., & Cummings, J. L. (2014) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000362715 · Cited by 34
Iacono, D., & Feltis, G. C. (2019) · Aging · doi:10.18632/aging.101757 · Cited by 36
Phillips, J. S., Nitchie, F. J., Re, F. D., Olm, C. A., Cook, P. A., McMillan, C. T., Irwin, D. J., Gee, J. C., Dubroff, J. G., Grossman, M., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12456 · Cited by 33
MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies
Inguanzo, A., Poulakis, K., Mohanty, R., Schwarz, C. G., Przybelski, S. A., Diaz‐Galvan, P., Lowe, V. J., Boeve, B. F., Lemstra, A. W., Beek, M. H. C. T. V., et al. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00448-6 · Cited by 31
Sun, Y., Lin, J., & Zhang, L. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.12.59 · Cited by 31
Ferreira, D., Mohanty, R., Murray, M. E., Nordberg, A. K., Kantarci, K., & Westman, E. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01471-z · Cited by 35
Self-citationNemes, S., Logan, P. E., Manchella, M. K., Mundada, N. S., Joie, R. L., Polsinelli, A. J., Hammers, D. B., Koeppe, R. A., Foroud, T., Nudelman, K. N. H., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13403 · Cited by 32
Self-citationAge and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia
Knopman, D. S., Jack, C. R., Wiste, H. J., Weigand, S. D., Vemuri, P., Lowe, V. J., Kantarci, K., Gunter, J. L., Senjem, M. L., Mielke, M. M., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002979 · Cited by 30
Self-citationNeuropathological Changes in Dementia With Lewy Bodies and the Cingulate Island Sign
Patterson, L., Firbank, M., Colloby, S. J., Attems, J., Thomas, A. J., & Morris, C. M. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlz047 · Cited by 30
Stage, E., Svaldi, D. O., Phillips, M. L., Canela, V. H., Duran, T., Goukasian, N., Risacher, S. L., Saykin, A. J., Apostolova, L. G., & Initiative, A. D. N. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00647-w · Cited by 30
Clinical relevance of brain atrophy subtypes categorization in memory clinics
Planche, V., Bouteloup, V., Mangin, J., Dubois, B., Delrieu, J., Pasquier, F., Blanc, F., Paquet, C., Hanon, O., Gabelle, A., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12231 · Cited by 32
Mohanty, R., Ferreira, D., Nordberg, A. K., Westman, E., & Initiative, T. A. D. N. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01173-1 · Cited by 30
Fully automated structural MRI of the brain in clinical dementia workup
Persson, K., Selbæk, G., Brækhus, A., Beyer, M. K., Barca, M. L., & Engedal, K. (2016) · Acta Radiologica · doi:10.1177/0284185116669874 · Cited by 30
18F‐AV‐1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy
Nedelská, Z., Josephs, K. A., Graff‐Radford, J., Przybelski, S. A., Lesnick, T. G., Boeve, B. F., Drubach, D. A., Knopman, D. S., Petersen, R. C., Jack, C. R., et al. (2019) · Movement Disorders · doi:10.1002/mds.27603 · Cited by 30
Self-citationFan, Y., Yuan, J., Somekh, J., Mor Peleg, B., Zhu, Y., Jia, Z., Wu, F. L., & Huang, Z. (2025) · Science Advances · doi:10.1126/sciadv.adr3757 · Cited by 30
de Souza, L. C., Lehéricy, S., Dubois, B., Stella, F., & Sarazin, M. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328357b9ab · Cited by 28
Toxic Protein Spread in Neurodegeneration: Reality versus Fantasy
Kara, E., Marks, J. D., & Aguzzi, A. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.09.004 · Cited by 30
Deepen into sleep and wake patterns across Alzheimer's disease phenotypes
Falgàs, N., Walsh, C. M., Neylan, T. C., & Grinberg, L. T. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12304 · Cited by 28
Vasilopoulou, F., Rodríguez‐Arévalo, S., Bagán, A., Escolano, C., Griñán‐Ferré, C., & Pallàs, M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15478 · Cited by 29
Reddy, J. S., Allen, M., Ho, C. C. G., Oatman, S. R., İş, Ö., Quicksall, Z., Wang, X., Jin, J., Patel, T., Carnwath, T., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01199-2 · Cited by 28
Self-citationMulticenter 18F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer’s Disease
Rullmann, M., Brendel, M., Schroeter, M. L., Saur, D., Levin, J., Perneczky, R. G., Tiepolt, S., Patt, M., Mueller, A., Villemagne, V. L., et al. (2022) · Biomolecules · doi:10.3390/biom12030458 · Cited by 29
TREM2 risk variants are associated with atypical Alzheimer’s disease
Kim, B., Suh, E. R., Nguyen, A. T., Prokop, S., Mikytuck, B., Olatunji, O. A., Robinson, J. L., Grossman, M., Phillips, J. S., Irwin, D. J., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02495-4 · Cited by 30
Lu, J., Zhang, Z., Wu, P., Liang, X., Zhang, H., Hong, J., Clement, C., Yen, T., Ding, S., Wang, M., et al. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103416 · Cited by 31
Aluminium in Brain Tissue in Epilepsy: A Case Report from Camelford
Mold, M. J., Cottle, J., & Exley, C. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16122129 · Cited by 29
Neuropathology, Neuroimaging, and Fluid Biomarkers in Alzheimer’s Disease
Colvee-Martin, H., Parra, J. R., Gonzalez, G. A., Barker, W., & Duara, R. (2024) · Diagnostics · doi:10.3390/diagnostics14070704 · Cited by 32
Self-citationDefault mode network tau predicts future clinical decline in atypical early Alzheimer’s disease
Katsumi, Y., Howe, I., Eckbo, R., Wong, B., Quimby, M., Hochberg, D., McGinnis, S. M., Putcha, D., Wolk, D. A., Touroutoglou, A., et al. (2024) · Brain · doi:10.1093/brain/awae327 · Cited by 31
Chen, Y., Liu, Z., Zhang, J., Chen, K., Li, Y., Li, X., Gong, G., Wang, J., & Zhang, Z. (2016) · Human Brain Mapping · doi:10.1002/hbm.23359 · Cited by 29
TDP-43 and Alzheimer’s Disease Pathologic Subtype in Non-Amnestic Alzheimer’s Disease Dementia
Sahoo, A., Bejanin, A., Murray, M. E., Tosakulwong, N., Weigand, S. D., Serie, A. M., Senjem, M. L., Machulda, M. M., Parisi, J. E., Boeve, B. F., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180169 · Cited by 28
Self-citationTabatabaei-Jafari, H., Shaw, M. E., Walsh, E., & Cherbuin, N. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.08.033 · Cited by 29
Arezoumandan, S., Xie, S. X., Cousins, K. A. Q., Mechanic-Hamilton, D. J., Peterson, C. S., Huang, C. Y., Ohm, D. T., Ittyerah, R., McMillan, C. T., Wolk, D. A., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02472-x · Cited by 29
Mesulam, M. M., Gefen, T. D., Flanagan, M. E., Castellani, R. J., Jamshidi, P., Barbieri, E., Sridhar, J., Kawles, A., Weıntraub, S., Geula, C., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26677 · Cited by 28
Bimanual Gesture Imitation in Alzheimer’s Disease
Sanin, G., & Benke, T. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-160680 · Cited by 27
Baiardi, S., Hansson, O., Levin, J., & Parchi, P. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14039 · Cited by 27
Metadata
- Authors
- Murray, M. E., Graff-Radford, N. R., Ross, O. A., Petersen, R. C., Duara, R., & Dickson, D. W.
- Affiliations
- Mayo Clinic (US)
- Mount Sinai Medical Center (US)
- Corresponding author
- Dickson, Dennis W
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 10
- Issue
- 9
- Pages
- 785-796
- ISSN
- 1474-4422 (ISSN-L)
- PMC
- PMC3175379
- OpenAlex
- W2075444764
- Cited by
- 972
- References
- 44
- Citations by year
- 2026: 60 · 2025: 80 · 2024: 78 · 2023: 96 · 2022: 80 · 2021: 104 · 2020: 70 · 2019: 73 · 2018: 56 · 2017: 50 · 2016: 55 · 2015: 37 · 2014: 36 · 2013: 54 · 2012: 35
- FWCI
- 29.28
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Lancet Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Mayo Clinic
- National Institutes of Health
- National Institute on Aging (P50‐AG16574, U01AG06786, P50 AG215711, P01AG03949, U01AG006786, P01AG003949, R21AG038736, P50AG025711, P01AG017216, P50AG016574)
- National Institute of Neurological Disorders and Stroke (P50NS072187)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, neurofibrillary tangles, Braak staging, hippocampal sparing, hippocampal atrophy, tau pathology, clinical features, atypical Alzheimer's disease, sex differences, age at death, genetic risk factors
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Female, Hippocampus, Humans, Limbic System, Male, Middle Aged, Retrospective Studies, Cohort Studies, Neurofibrillary Tangles, tau Proteins, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
